Novartis Cancer Drug Beneficial To Parkinson's Disease Patients, Reveals Early Stage Trial

Drug meant to treat leukemia shows promise of halting or even reversing the symptoms of Parkinson's, researchers find. Finding of small trial spurs scientists to plan larger trials to test drug with Parkinson's, Alzheimer's.